Serum soluble interleukin-2 receptor in eosinophilia

被引:5
作者
Kaito, K
Otsubo, H
Ogasawara, Y
Kimura, H
Kurihara, E
Koike, M
Aiso, M
Kobayashi, M
机构
[1] Jikei Univ Hosp, Cent Clin Lab, Minato Ku, Tokyo 1058471, Japan
[2] Jikei Univ, Sch Med, Dept Internal Med, Div Hematol & Oncol, Tokyo, Japan
关键词
eosinophilia; IgE; interleukin-2; receptor; soluble;
D O I
10.1159/000067274
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between soluble interleukin-2 receptor (sIL-2R) levels and clinical characteristics was evaluated in patients with eosinophilia. Thirty-eight out of 60 patients showed sIL-2R levels of more than 800 U/ml. In these patients, sIL-2R was closely related to the eosinophil count, but not the IgE level. Their underlying diseases were heterogeneous, including neoplasms and collagen diseases. In patients with lower sIL-2R levels, there was no relationship to the eosinophil count, but sIL-2R was correlated with the IgE level. These findings indicate that patients with eosinophilia and higher sIL-2R levels tend to have underlying diseases other than allergy, and might be more severely ill than patients with lower sIL-2R levels. sIL-2R may be a good marker for evaluating patients with eosinophilia, as an indicator of the probable etiology and severity of their diseases. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:23 / 28
页数:6
相关论文
共 12 条
[1]   MOLECULAR-CLONING, NUCLEOTIDE-SEQUENCE, AND EXPRESSION OF THE GENE ENCODING HUMAN EOSINOPHIL DIFFERENTIATION FACTOR (INTERLEUKIN-5) [J].
CAMPBELL, HD ;
TUCKER, WQJ ;
HORT, Y ;
MARTINSON, ME ;
MAYO, G ;
CLUTTERBUCK, EJ ;
SANDERSON, CJ ;
YOUNG, IG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (19) :6629-6633
[2]   INCREASED LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN NON-HODGKINS LYMPHOMAS - RELATIONSHIP WITH CLINICAL, HISTOLOGIC, AND PHENOTYPIC FEATURES [J].
CHILOSI, M ;
SEMENZATO, G ;
VINANTE, F ;
MENESTRINA, F ;
PIAZZOLA, E ;
FOCCHIATTI, V ;
SABBIONI, R ;
ZANOTTI, R ;
PIZZOLO, G .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1989, 92 (02) :186-191
[3]  
Furue Masutaka, 1994, Journal of Dermatological Science, V7, P89, DOI 10.1016/0923-1811(94)90081-7
[4]  
LASSALLE P, 1992, CLIN EXP IMMUNOL, V87, P266
[5]  
MCKINLEY KL, 1993, MUSCLE NERVE, V16, P1228
[6]  
PRIN L, 1991, BLOOD, V78, P2626
[7]  
PUTTERMAN C, 1993, ANN ALLERGY, V70, P243
[8]   Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome [J].
Roufosse, F ;
Schandené, L ;
Sibille, C ;
Willard-Gallo, K ;
Kennes, B ;
Efira, A ;
Goldman, M ;
Cogan, E .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (03) :540-548
[9]   EOSINOPHIL DIFFERENTIATION FACTOR ALSO HAS B-CELL GROWTH-FACTOR ACTIVITY - PROPOSED NAME INTERLEUKIN-4 [J].
SANDERSON, CJ ;
OGARRA, A ;
WARREN, DJ ;
KLAUS, GGB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (02) :437-440
[10]  
SONODA Y, 1989, LEUKEMIA, V3, P14